Allspring Global Investments
ORIC icon

Allspring Global Investments’s Oric Pharmaceuticals ORIC Stock Holding History

Allspring Global Investments’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,414
Closed -$20.7K – 2587
2023
Q3 		$20.7K Buy
+3,414
New +$28K ﹤0.01% 2503
2022
Q3 		– Sell
-65,716
Closed -$294K – 2934
2022
Q2 		$294K Sell
65,716
-916,438
-93% -$3.66M ﹤0.01% 1710
2022
Q1 		$5.24M Sell
982,154
-18,045
-2% -$163K 0.01% 1126
2021
Q4 		$14.7M Buy
+1,000,199
New +$15.6M 0.02% 807

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return